BioSpace News Archive

Pharm Country

Royal Biologics Announces U.S. Commercial Launch of Advanced-Cell™, an Advanced Bone Grafting and Fusion Convenience Kit

Royal Biologics (Hackensack, NJ), a company specializing in Advanced Cellular & Autologous Technologies for Enhanced Healing, today announced the U.S. commercial launch of Advanced - Cell™, an advanced fusion bone grafting system for use in orthopedics.

April 26, 2022
·
3 min read
Veterinary Medicine Market Size to Surpass US$ 55.8 BN by 2030

The global veterinary medicine market size is expected to surpass around US$ 55.8 billion by 2030 from valued at US$ 30.2 billion in 2020 with CAGR of 8.4% from 2021 to 2030.

April 26, 2022
·
5 min read
Pharm Country

Albert Einstein College of Medicine Receives $4.2 Million NIH Grant to Discover Novel Markers of Early Alzheimer’s Disease

Diagnosing Alzheimer’s disease can be a complex and time-consuming process, requiring evaluations ranging from brain scans to cognitive and lab tests to reviews of medical history and symptoms.

April 26, 2022
·
4 min read
Business

BlueSphere Bio Appoints Robert Keefe, Ph.D. as Chief Development OfficerDr. Keefe to lead the product development and manufacturing of BlueSphere Bio’s first clinical candidate, a TCR T-cell therapy directed against the miHA HA-1.

BlueSphere Bio announced the appointment of industry veteran Robert Keefe, Ph.D., to its executive team as chief development officer.

April 26, 2022
·
2 min read
Colchicine Market Size 2022-2030- Increasing Clinical Studies Of Colchicine Drugs For Various Applications

Increasing incidences of gout across the globe and increasing prevalence of other related diseases such as Familial Mediterranean Fever (FMF) and arthritis are some major factors driving market revenue growth.

April 26, 2022
·
8 min read
Drug Development

AMRA Medical’s MRI-based body composition measurements used in Lilly’s SURPASS-3 tirzepatide sub-study

AMRA’s quantitative body composition method was used in Eli Lilly and Company’s magnetic resonance imaging (MRI) sub-study of the phase 3 SURPASS-3 clinical trial (trial NCT03882970) to assess the impact of tirzepatide (5 mg, 10 mg, 15 mg) on various fat depots in individuals with Type 2 Diabetes (T2DM).

April 26, 2022
·
2 min read
94th Vifor Pharma Group Annual General Meeting

At 94th Annual General Meeting of Vifor Pharma Ltd., shareholders approved all proposed resolutions put forward by the Board of Directors.

April 26, 2022
·
2 min read
ShiftBio Partners with RoosterBio to Accelerate Development of a Novel Genetically Engineered Exosome, SBI-102 for Rare Diseases and Cancer

RoosterBio’s MSC-derived exosome bioprocess technology platform enables accelerated development of ShiftBio’s lead therapeutic candidate via a scalable cGMP manufacturing process in bioreactors, downstream purification, and analytical characterization.

April 26, 2022
·
4 min read
Center TRT Seeking Men 30-50 For Trial Studying Efficacy Of Over The Counter Testosterone Supplements

Center TRT is a research institute based in the United States, with a team that has a long history of public health and evidence-based research policy, they are looking to run a study determining the true efficacy of testosterone supplements.

April 26, 2022
·
2 min read
Biopharmaceutical Third Party Logistics Market Size US$ 150.2 BN 2030

The global biopharmaceutical third party logistics market size is expected to surpass around US$ 150.2 billion by 2030 and expanding growth at a CAGR of 6.6% from 2021 to 2030.

April 26, 2022
·
3 min read